DGX Quest Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NYSE: DGX

Price (delayed)

$250.81

Market cap

$27.59B

P/E Ratio

24.64

Dividend/share

$3.38

EPS

$10.18

Enterprise value

$33.08B

?
Relative Growth: Rel. Growth: 56
Relative Strength: Rel. Strength: 84
Relative Valuation: Rel. Valuation: 58
Relative Profitability: Rel. Profitability: 67

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path ...

Highlights
Quest Diagnostics's quick ratio has surged by 56% YoY and by 7% QoQ
DGX's EPS is up by 18% year-on-year and by 7% since the previous quarter
DGX's price to earnings (P/E) is 35% higher than its 5-year quarterly average of 18.2 and 15% higher than its last 4 quarters average of 21.5
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.questdiagnostics.com
Peers: LH NEO QGEN

Key stats

What are the main financial stats of DGX

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-0.4%
1 week
3.24%
1 month
7.49%
1 year
42.55%
YTD
44.53%
QTD
7.61%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$11.84B
Gross profit
$3.92B
Operating income
$1.72B
Net income
$1.13B
Gross margin
33.1%
Net margin
9.5%
The net income has grown by 17% YoY and by 6% from the previous quarter
DGX's operating income is up by 13% year-on-year and by 6% since the previous quarter
The revenue has grown by 9% YoY and by 2.4% from the previous quarter
The gross profit has increased by 9% YoY and by 2.4% from the previous quarter

Price vs fundamentals

How does DGX's price correlate with its fundamentals

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
DGX P/E details
P/E
24.64
P/B
3.63
P/S
2.33
EV/EBIT
19.21
EV/EBITDA
14.34
EV/Sales
2.79
DGX's price to earnings (P/E) is 35% higher than its 5-year quarterly average of 18.2 and 15% higher than its last 4 quarters average of 21.5
DGX's EPS is up by 18% year-on-year and by 7% since the previous quarter
The stock's price to book (P/B) is 34% more than its 5-year quarterly average of 2.7 and 21% more than its last 4 quarters average of 3.0
Quest Diagnostics's equity has increased by 5% YoY
The stock's price to sales (P/S) is 37% more than its 5-year quarterly average of 1.7 and 17% more than its last 4 quarters average of 2.0
The revenue has grown by 9% YoY and by 2.4% from the previous quarter

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on assets is up by 12% year-on-year and by 4.7% since the previous quarter
DGX's ROE is up by 11% year-on-year and by 4.8% since the previous quarter
Quest Diagnostics's return on invested capital has increased by 11% YoY and by 2.9% QoQ
DGX's return on sales is up by 2.8% year-on-year and by 2.1% since the previous quarter

Dividends

What is DGX's dividend history
Dividend details
DPS
$3.38
Dividend yield
1.35%
Payout ratio
33.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 86% greater than the total liabilities
Quest Diagnostics's quick ratio has surged by 56% YoY and by 7% QoQ
The current ratio has soared by 50% YoY and by 7% QoQ
Quest Diagnostics's debt is 18% lower than its equity
The company's debt to equity fell by 7% YoY and by 3.5% QoQ
Quest Diagnostics's equity has increased by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.